MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The efficacy of Botulinum toxin A in reducing muscle spasticity by different volumes of dilution

    R. Marvulli, G. Ianieri, G. Mintrone, A. Zonno, L. Rizzo, G. Farì, M. Ranieri, M. Megna (Bari, Italy)

    Objective: Spasticity is a speed-dependent increase in muscle tone associated with stiffness, enhanced osteotendinous reflexes, paresis, loss of fine motor control, and increased fatigue. The…
  • 2022 International Congress

    Cognitive dysfunction in cervical dystonia

    M. Diepman, S. Rafee, M. Hutchinson, R. Sommers, F. O'Keeffe (Dublin 4, Ireland)

    Objective: To assess prevalence of anxiety and depression in patients with CD and investigate cognitive changes including social cognition and executive function. Background: Cervical dystonia,…
  • 2022 International Congress

    The Genetic Landscape of Parkinson’s disease in populations of non-Caucasian ancestry.

    C. Koros, AM. Simitsi, N. Papagiannakis, A. Bougea, I. Pachi, R. Antonelou, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: We aimed to review existing literature on the genetic background of Parkinson’s disease (PD) populations of non-Caucasian or mixed ancestry. Background: There has been…
  • 2022 International Congress

    Effect of Aspartame on Parkinson’s Disease Progression and Severity

    D. Kushigian, O. Vaou (Boston, USA)

    Objective: The purpose of this review was to assess the current evidence regarding the effect of aspartame (APM) consumption on Parkinson’s Disease (PD) severity. Background:…
  • 2022 International Congress

    Neuropathological profile of tauopathy in spinocerebellar ataxia type 8

    G. Beck, Y. Yonenobu, R. Yamashita, T. Iwaki, S. Murayama, H. Mochizuki (Suita, Japan)

    Objective: The purpose of this study is to examine the distribution of tau pathology in brain regions of patients with spinocerebellar ataxia type 8 (SCA8).…
  • 2022 International Congress

    Body-first and brain-first PD animal models mimic human PD subtypes

    N. Vanden Berge, M. Pedersen, I. Klæstrup, J. Jacobsen, M. Simonsen, A. Alstrup, M. Romero-Ramos, P. Borghammer (Aarhus N, Denmark)

    Objective: Here, we aim to model body- and brain-first PD by injecting pathology in the gut and amygdala of old wild-type rats, respectively. Background: Parkinson’s…
  • 2022 International Congress

    Clinical and risk profiles of Parkinson’s disease from a large pan-India cohort: interim observations of the GAP-India study

    A. Kishore, R. Borgohain, R. Rajan, K. Divya, L. Prashanth, P. Pal, S. Mehta, H. Kumar, N. Kumar, S. Desai, R. Kamdadai, S. Krishnan, M. Chacko, M. Sharma (Kochi, India)

    Objective: To create a pan-Indian clinical repository of Parkinson’s Disease (PD). Background: The genetic risk for PD in India is unknown. The Luxembourg-German India Alliance…
  • 2022 International Congress

    Digital Sway Measures for Spinocerebellar Ataxia

    V. Shah, J. Mcnames, H. Casey, K. Floyd, R. Rodriguez-Labrada, J. Schmahmann, L. Rosenthal, S. Perlman, M. El Gohary, K. Sowalsky,, M. Mancini, L. Velázquez-Pérez, F. Horak, C. Gomez (Portland, USA)

    Objective: The objective of the study was to investigate which postural sway condition and which measures are most sensitive to prodromal and manifest spinocerebellar ataxia…
  • 2022 International Congress

    Social Withdrawal in Parkinson’s Disease: A Scoping Review

    S. Ahn, K. Springer, J. Gibson (Charlottesville, USA)

    Objective: We conducted a scoping review to understand the nature and impacts of social withdrawal in PD and identify evidence gaps. Background: Social withdrawal has…
  • 2022 International Congress

    A secretory vesicle failure in Parkinson’s disease occurs in human platelets

    P. Montenegro, M. Pueyo, JN. Lorenzo, R. González-Brito, A. Méndez, R. Borges (La Laguna, Spain)

    Objective: Since platelets use similar, if not the same, mechanisms to accumulate serotonin (5-HT) as dopaminergic neurons to store DA in their VS; we wonder…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley